2025-524911-34-00招募中1 期
A Phase I Study to Evaluate ELA822
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 45
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Sandra Ospina
Scientific
Electra Therapeutics Inc.
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
A Phase 1 Study of EA8001 in Healthy Adult SubjectsSchizophreniajRCT205126005027
招募中
1 期
A Phase 1 Study on the effects of LY3410738 (study drug) administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations2024-515150-24-00Eli Lilly & Co.3
招募中
1 期
A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin LymphomaNCT07432022Shanghai EpimAb Biotherapeutics Co., Ltd.115
招募中
1 期
EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal adenocarcinoma, round cell liposarcoma and/or synovial sarcomaSynovial Sarcoma2024-516787-28-00Medigene AG20
尚未招募
不适用
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naive High-grade Non-muscle Invasive Bladder Cancer (ADVANCED-3)Non-Muscle Invasive Bladder CarcinomajRCT204126009128